drugset / Trial / NCT06164834

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects

NCT06164834

Phase 1 Unknown 48 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the effects of tegoprazan or esomeprazole administered in combination with clopidogrel on the pharmacodynamics/Pharmacokinetics of clopidogrel in healthy adults

Timeline

Start
2023-12-05
Primary completion
2024-11
Completion
2024-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg Oral
Subject Esomeprazole Small molecule 20 mg Oral
Subject Tegoprazan Other / unclassified 25 mg Oral

Indications

No indication recorded.